Klaus F. Rabe

Has grant

Professor of Pulmonary Medicine

Christian-Albrechts-Universität zu Kiel

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Telementor COPD - TELEMEdizinisches moNiTORing COPD

Open Date: 2021-01-01

Close Date: 2024-01-01

Grant: Close

EXC 2167: Precision Medicine in Chronic Inflammation (PMI)

Open Date: 2019-01-01

Close Date:

Grant: Close

Clinician Scientist Program in Evolutionary Medicine

Open Date: 2018-01-01

Close Date:

Grant: Close

German Center for Lung Research (DZL)

Open Date: 2011-01-01

Close Date:

Grant: Close

EXC 306: Inflammation at Interfaces

Open Date: 2007-01-01

Close Date: 2018-12-31

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (6)

Mona Bafadhel

King’s College London

UNITED KINGDOM

View details

William Busse

Professor of Medicine

University of Wisconsin School of Medicine and Public Health

UNITED STATES

View details

Stefan Andreas

Head

GERMANY

View details

Ian Pavord

Professor of Respiratory Medicine/Honorary Consultant Physician

University of Oxford

UNITED KINGDOM

View details

Dave Singh

The University of Manchester

UNITED KINGDOM

View details

Peter Alter

Prof, MD, FESC

University of Marburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Klaus F. Rabe

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook

Dupilumab improves long‐term outcomes in patients with uncontrolled, moderate‐to‐severe GINA‐based type 2 asthma, irrespective of allergic status

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD

Predictive modeling of COPD exacerbation rates using baseline risk factors

Key summary of German national treatment guidance for hospitalized COVID-19 patients (Jul, 10.1007/s15010-021-01645-2, 2021)

Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial

Collaborators (6)

Mona Bafadhel

William Busse

Stefan Andreas

Ian Pavord

Dave Singh

Peter Alter

Make your next move.